159 related articles for article (PubMed ID: 38006099)
1. Microfluidic-Assisted Formulation of ε-Polycaprolactone Nanoparticles and Evaluation of Their Properties and In Vitro Cell Uptake.
Rybak E; Kowalczyk P; Czarnocka-Śniadała S; Wojasiński M; Trzciński J; Ciach T
Polymers (Basel); 2023 Nov; 15(22):. PubMed ID: 38006099
[TBL] [Abstract][Full Text] [Related]
2. Microfluidic-assisted nanoprecipitation of biodegradable nanoparticles composed of PTMC/PCL (co)polymers, tannic acid and doxorubicin for cancer treatment.
Brzeziński M; Socka M; Makowski T; Kost B; Cieślak M; Królewska-Golińska K
Colloids Surf B Biointerfaces; 2021 May; 201():111598. PubMed ID: 33618081
[TBL] [Abstract][Full Text] [Related]
3. Paclitaxel-Loaded TPGS-b-PCL Nanoparticles: In Vitro Cytotoxicity and Cellular Uptake in MCF-7 and MDA-MB-231 Cells versus mPEG-b-PCL Nanoparticles and Abraxane®.
Bernabeu E; Gonzalez L; Legaspi MJ; Moretton MA; Chiappetta DA
J Nanosci Nanotechnol; 2016 Jan; 16(1):160-70. PubMed ID: 27398441
[TBL] [Abstract][Full Text] [Related]
4. Development of Statistically Optimized Piperine-Loaded Polymeric Nanoparticles for Breast Cancer: In Vitro Evaluation and Cell Culture Studies.
Gilani SJ; Bin-Jumah MN; Fatima F
ACS Omega; 2023 Nov; 8(46):44183-44194. PubMed ID: 38027324
[TBL] [Abstract][Full Text] [Related]
5. Uptake mechanism of furosemide-loaded pegylated nanoparticles by cochlear cell lines.
Youm I; Youan BB
Hear Res; 2013 Oct; 304():7-19. PubMed ID: 23747541
[TBL] [Abstract][Full Text] [Related]
6. Development and Optimization of Acriflavine-Loaded Polycaprolactone Nanoparticles Using Box-Behnken Design for Burn Wound Healing Applications.
Nawaz T; Iqbal M; Khan BA; Nawaz A; Hussain T; Hosny KM; Abualsunun WA; Rizg WY
Polymers (Basel); 2021 Dec; 14(1):. PubMed ID: 35012125
[TBL] [Abstract][Full Text] [Related]
7. Assessing the physical-chemical properties and stability of dapivirine-loaded polymeric nanoparticles.
das Neves J; Amiji M; Bahia MF; Sarmento B
Int J Pharm; 2013 Nov; 456(2):307-14. PubMed ID: 24012910
[TBL] [Abstract][Full Text] [Related]
8. Chitosan functionalized PCL nanoparticles bearing tyrosine kinase inhibitor osimertinib mesylate for effective lung cancer therapy.
Dhuri A; Sriram A; Aalhate M; Mahajan S; Parida KK; Singh H; Gupta U; Maji I; Guru SK; Singh PK
Pharm Dev Technol; 2023 Jun; 28(5):460-478. PubMed ID: 37092801
[TBL] [Abstract][Full Text] [Related]
9. Aminocellulose-Grafted Polymeric Nanoparticles for Selective Targeting of CHEK2-Deficient Colorectal Cancer.
Ahmad A; Ansari MM; Verma RK; Khan R
ACS Appl Bio Mater; 2021 Jun; 4(6):5324-5335. PubMed ID: 35007013
[TBL] [Abstract][Full Text] [Related]
10. Peptide loaded polymeric nanoparticles by non-aqueous nanoprecipitation.
Haim Zada M; Rottenberg Y; Domb AJ
J Colloid Interface Sci; 2022 Sep; 622():904-913. PubMed ID: 35561610
[TBL] [Abstract][Full Text] [Related]
11. Physical PEGylation Enhances The Cytotoxicity Of 5-Fluorouracil-Loaded PLGA And PCL Nanoparticles.
Ashour AE; Badran M; Kumar A; Hussain T; Alsarra IA; Yassin AEB
Int J Nanomedicine; 2019; 14():9259-9273. PubMed ID: 31819428
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol-Loaded Polymeric Nanoparticles: The Effects of D-α-Tocopheryl Polyethylene Glycol 1000 Succinate (TPGS) on Physicochemical and Biological Properties against Breast Cancer In Vitro and In Vivo.
Cavalcante de Freitas PG; Rodrigues Arruda B; Araújo Mendes MG; Barroso de Freitas JV; da Silva ME; Sampaio TL; Petrilli R; Eloy JO
Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345140
[TBL] [Abstract][Full Text] [Related]
13. Effect of different molecular weight PLGA on flurbiprofen nanoparticles: formulation, characterization, cytotoxicity, and
Öztürk AA; Yenilmez E; Şenel B; Kıyan HT; Güven UM
Drug Dev Ind Pharm; 2020 Apr; 46(4):682-695. PubMed ID: 32281428
[No Abstract] [Full Text] [Related]
14. Production of doxorubicin-loaded PCL nanoparticles through a flow-focusing microfluidic device: encapsulation efficacy and drug release.
Heshmatnezhad F; Solaimany Nazar AR; Aghaei H; Varshosaz J
Soft Matter; 2021 Dec; 17(47):10675-10682. PubMed ID: 34782908
[TBL] [Abstract][Full Text] [Related]
15. Improved antitumor activity and reduced toxicity of doxorubicin encapsulated in poly(ε-caprolactone) nanoparticles in lung and breast cancer treatment: An in vitro and in vivo study.
Cabeza L; Ortiz R; Prados J; Delgado ÁV; Martín-Villena MJ; Clares B; Perazzoli G; Entrena JM; Melguizo C; Arias JL
Eur J Pharm Sci; 2017 May; 102():24-34. PubMed ID: 28219748
[TBL] [Abstract][Full Text] [Related]
16. Paclitaxel-loaded PCL-TPGS nanoparticles: in vitro and in vivo performance compared with Abraxane®.
Bernabeu E; Helguera G; Legaspi MJ; Gonzalez L; Hocht C; Taira C; Chiappetta DA
Colloids Surf B Biointerfaces; 2014 Jan; 113():43-50. PubMed ID: 24060929
[TBL] [Abstract][Full Text] [Related]
17. [Preparation and in vitro evaluation of rhein-loaded PEG-PCL-PEI nanoparticles].
Chen DF; Zhu YQ; Zhang Y; Wang LY; Wei YH
Zhongguo Zhong Yao Za Zhi; 2017 Aug; 42(16):3121-3130. PubMed ID: 29171230
[TBL] [Abstract][Full Text] [Related]
18. Fabrication of genistein-loaded biodegradable TPGS-b-PCL nanoparticles for improved therapeutic effects in cervical cancer cells.
Zhang H; Liu G; Zeng X; Wu Y; Yang C; Mei L; Wang Z; Huang L
Int J Nanomedicine; 2015; 10():2461-73. PubMed ID: 25848264
[TBL] [Abstract][Full Text] [Related]
19. Optimization of Bromocriptine-Mesylate-Loaded Polycaprolactone Nanoparticles Coated with Chitosan for Nose-to-Brain Delivery: In Vitro and In Vivo Studies.
Badran MM; Alanazi AE; Ibrahim MA; Alshora DH; Taha E; H Alomrani A
Polymers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835942
[TBL] [Abstract][Full Text] [Related]
20. Optimization to development of chitosan decorated polycaprolactone nanoparticles for improved ocular delivery of dorzolamide: In vitro, ex vivo and toxicity assessments.
Shahab MS; Rizwanullah M; Alshehri S; Imam SS
Int J Biol Macromol; 2020 Nov; 163():2392-2404. PubMed ID: 32979440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
